SXSW 2019

Blockchain Transforming Big Pharma

Description:

The complexity of data sharing, lack of visibility, coordination and trust between patients and pharmaceutical companies make drug development process expensive and ineffective. We will examine the current state of blockchain and specific use cases in pharmaceutical industry, attempting to democratize drug development. Optimized patient consent, clinical trial recruitment and retention, clinical data immutability and drug supply chain will lead to improvement in research and lowering of drug costs.


Other Resources / Information


Takeaways

  1. TBD
  2. TBD
  3. TBD

Speakers

  • Kate Gofman, patient safety physician, associate director , AstraZeneca
  • Frank Pok, US Tech Incubation Lead, AstraZeneca

Organizer

Kate Gofman, safety physician, associate director, AstraZeneca


Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Blockchain & Cryptocurrency
  • Track 2
  • Level: Advanced


Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.